Skip to main content
Richard Dunne, MD, Oncology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

RichardF.DunneMD

Oncology • Rochester, NY

Gastrointestinal Cancer, Hematologic Oncology

Associate Professor of Medicine, Leader of the Gastrointestinal Cancer Unit and Clinical Research Program, Wilmot Cancer Institute, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Dunne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dunne's full profile

Already have an account?

Education & Training

  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryMasters in Clinical Investigation, Clinical Research, 2016 - 2019
  • University of Rochester
    University of RochesterPost-Doctoral Fellowship, Fellowship in Cancer Control and Supportive Care Oncology, 2016 - 2018
  • University of Rochester
    University of RochesterFellowship, Hematology and Medical Oncology, 2013 - 2015
  • University of Rochester
    University of RochesterChief Residency, Internal Medicine, 2012 - 2013
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 2009 - 2012
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2009

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2025

Awards, Honors, & Recognition

  • Cancer Grand Challenges: Cachexia-Understand and Reverse Cachexia NCI and CRUK
  • KL2 Mentored Career Development Award: Randomized Interventional Trial Investigating Dietary Supplementation and Exercise in Cancer Cachexia University of Rochester Clinical and Translational Science Institute, 2019-2021
  • NCI R25 Workshop in Supportive Care and Oncology Grantee Mass General Hospital, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer  
    Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature

Lectures

  • Evaluating the effects of a structured exercise intervention on physical self-worth in men with prostate cancer: Addressing an unmet need. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

  • Summer Internship Program Helps Wilmot Blaze a More Diverse Path in Oncology
    Summer Internship Program Helps Wilmot Blaze a More Diverse Path in OncologyFebruary 8th, 2022
  • Clinical Problems of Patients with Cachexia Due to Chronic Illness: A Congress Report
    Clinical Problems of Patients with Cachexia Due to Chronic Illness: A Congress ReportOctober 4th, 2020
  • Study Points to Obesity as Driver of Pancreatic Cancer
    Study Points to Obesity as Driver of Pancreatic CancerApril 16th, 2020
  • Join now to see all

Grant Support

  • The Pancreatic Cancer Tumor Genome and its Influence on the Development of Cancer CachexiaUniversity of Rochester Department of Medicine2017–2018
  • Evaluating the Effects of a 12 week Home-based Exercise Intervention on Physical Performance in Patients with Cancers of the Gastrointestinal Tract with Pre-cachexia or Cachexia: A pilot study.Wilmot Foundation for Cancer Research2015–2018

Professional Memberships

Hospital Affiliations

Dr. Richard Dunne, Dr. Richard Dunne, MD, Dr. R Dunne, Dr. Richard F. Dunne